Financial Data and Key Metrics Changes - First quarter revenue was $770.5 million, slightly above the midpoint of the guidance range of $765 million to $775 million [6] - Adjusted EBITDA for the first quarter was $134.2 million, near the high end of the guidance range of $130 million to $135 million [6] - Same facility patient days grew by 2.2% in the first quarter, impacted by an unfavorable leap year effect of approximately 110 basis points [6][15] - Adjusted EBITDA margin was 17.4% for the first quarter [16] Business Line Data and Key Metrics Changes - Same facility revenue grew by 2.1% year-over-year, driven by patient day growth of 2.2% [15] - Same facility adjusted EBITDA was $191.6 million, with an adjusted EBITDA margin of 25.2% [17] - Start-up losses related to new facilities were higher year-over-year and sequentially, reflecting an increase in newly constructed facilities [16] Market Data and Key Metrics Changes - Acadia added 378 new beds in the first quarter, including 90 beds to existing facilities and 288 beds from two new facilities [7] - The company expects to add between 800 to 1,000 total beds for the full year 2025 [18] Company Strategy and Development Direction - Acadia's strategy focuses on high-quality care and clinical health outcomes, with a commitment to quality and safety as foundational elements [10] - The company aims to bridge the gap between physical and behavioral health care, enhancing relationships with referral sources and joint venture partners [7] - Acadia plans to continue expanding its market reach, with expectations to add between 600 to 800 beds annually from 2026 to 2028 [8][21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the demand for behavioral health services, particularly for higher acuity patients [39] - The company remains engaged in policy discussions to strengthen the behavioral health care system and expects continued support for essential care [12] - Management acknowledged the challenges posed by underperforming facilities but indicated that improvements are expected over time [17][19] Other Important Information - As of March 31, 2025, Acadia had $91.2 million in cash and cash equivalents and approximately $900 million available under its revolving credit facility [18] - The company repurchased approximately 1.6 million shares during the first quarter for a total of $47.3 million [18] Q&A Session Summary Question: Can you provide perspective on the progression of EBITDA and seasonality of the business this year? - Management highlighted several moving parts affecting EBITDA, including the timing of supplemental payments and the impact of start-up costs from new beds [25][28] Question: What are you seeing in Medicaid rate updates? - Management noted stable underlying rate growth and a cautious approach to assumptions due to policy uncertainties [32][34] Question: How is the broader demand environment for behavioral health? - Management indicated consistent demand for services, particularly for higher acuity patients, and ongoing efforts to meet that demand through new facilities and bed additions [39][41] Question: What is the expected return target for new facilities? - Management emphasized a disciplined approach to capital deployment, ensuring returns exceed the cost of capital [65][66] Question: How should we think about legal expenses moving forward? - Management is actively cooperating with ongoing investigations, and while it's difficult to predict future legal costs, significant preliminary work is being undertaken [73][74] Question: Can you provide guidance on Q2's percentage of annual guidance? - Management refrained from providing specific Q2 guidance but noted that supplemental payments, particularly from the Tennessee program, would be a significant swing factor [79][80] Question: What is happening with specialty revenue? - Management acknowledged a year-over-year decline in specialty revenue and indicated ongoing efforts to address this issue [104]

Core Insights - PAX Health has acquired Richardson Psychiatric Associates, enhancing its mental health service portfolio and expanding its geographic reach in Western Pennsylvania [1][2][5] - The acquisition aims to improve access to comprehensive behavioral healthcare and maintain the established patient care approach of Richardson Psychiatric Associates [5] Company Overview - PAX Health is a leading behavioral health company focused on providing innovative and comprehensive mental health solutions [6] - Richardson Psychiatric Associates offers outpatient psychiatric treatment for various age groups and provides services such as psychiatric evaluations and medication management [7] Leadership and Expertise - Dr. W. Randolph Richardson and Lisa Richardson co-founded Richardson Psychiatric Associates, bringing over thirty years of experience in the Western Pennsylvania market [4][8] - Dr. Richardson is board certified in psychiatry and has extensive training from Emory University and the University of Pittsburgh Medical Center [8]

Core Insights - Talkspace, a leading behavioral healthcare company, will release its Q1 2025 results on May 6, 2025, before market open and will host a conference call at 8:30am ET to discuss the results [1] Company Overview - Talkspace is a prominent virtual behavioral healthcare provider focused on improving mental health access and quality [3] - The company offers a range of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management for adults [4] - Talkspace's services are accessible through a fully-encrypted web and mobile platform that complies with HIPAA and other regulatory requirements [5] - Over 179 million Americans can access Talkspace services through various channels, including health insurance plans and employer-sponsored programs [5]

Group 1 - Acadia Healthcare Company, Inc. (ACHC) has been added to the Zacks Rank 5 (Strong Sell) List due to a 17.4% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Blackbaud, Inc. (BLKB) is also on the Zacks Rank 5 (Strong Sell) List, with a 6.7% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Cable One, Inc. (CABO) has been included in the Zacks Rank 5 (Strong Sell) List, with an 8.5% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2]

Core Viewpoint - Acadia Healthcare Company, Inc. is expected to report its fourth-quarter 2024 results on February 27, 2025, with earnings estimated at 72 cents per share and revenues of $779.89 million, indicating a year-over-year revenue growth of 5% despite a decline in earnings per share [1][2]. Financial Estimates - The fourth-quarter earnings estimate has decreased by 2 cents per share over the past 60 days, reflecting a year-over-year decrease of 15.3% in earnings [2]. - For the full year 2024, the revenue estimate for Acadia Healthcare is $3.16 billion, representing a year-over-year increase of 7.9%, while the EPS estimate is $3.38, indicating a decline of approximately 1.7% year-over-year [3]. Recent Performance - Acadia Healthcare has consistently beaten consensus earnings estimates in the last four quarters, with an average surprise of 3.9% [3]. - However, the current model indicates uncertainty regarding an earnings beat for the upcoming quarter, as the company has an Earnings ESP of -5.44% and a Zacks Rank of 4 (Sell) [4]. Revenue Drivers - Revenue estimates for Acute Inpatient Psychiatric Facilities are projected to increase nearly 6% from the previous year's figure of $375.6 million, while Residential Treatment Centers are expected to see a 23% increase from $84.3 million [6]. - U.S. same-facility patient days are anticipated to grow by 4% year-over-year, with admissions expected to rise by 3.1% [7]. Expense Considerations - Rising expenses are likely to impact profit levels, with total expenses expected to increase by more than 6% in the upcoming quarter due to higher salaries, professional fees, and operating costs [8]. - Supply costs are also projected to rise due to increased utilization [8]. Other Revenue Insights - Revenue estimates for Specialty Treatment Facilities are expected to decrease by nearly 2% from $151.3 million, and Comprehensive Treatment Centers are projected to see a 1.2% decline from $131.6 million [9].